Weight Loss Pro

Semaglutide + AOD 9604 — GLP-1 receptor agonism combined with lipolytic peptide research

Semaglutide is a GLP-1 receptor agonist that reduces appetite, delays gastric emptying, and improves insulin sensitivity. AOD-9604 is a fragment of GH (residues 177–191) that stimulates fat lipolysis via a non-GH-receptor mechanism with no effect on IGF-1 or blood glucose. The combination addresses both central appetite regulation and peripheral fat mobilisation.

For research purposes only. Not for human consumption.